| J B Chemicals & Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 506943 |
NSE Symbol : JBCHEPHARM |
P/E(TTM) : 40.56 |
|
ISIN Demat : INE572A01036 |
Div & Yield% : 0.84 |
EPS(TTM) : 44.97 |
|
Book Value(₹) : 237.66 |
Market Cap(₹Cr) : 28,571.90 |
Face Value(₹) : 1.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 1,022.65 | 1,039.90 | 901.34 | 913.51 | 955.76 | 952.31 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 1,022.65 | 1,039.90 | 901.34 | 913.51 | 955.76 | 952.31 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 14.25 | 13.90 | 13.53 | 7.16 | 8.89 | 5.16 |
| Total Income | 1,036.90 | 1,053.80 | 914.87 | 920.67 | 964.65 | 957.47 |
| Total Expenditure | 724.29 | 746.78 | 670.36 | 668.11 | 687.58 | 678.93 |
| PBIDT | 312.61 | 307.02 | 244.51 | 252.56 | 277.07 | 278.54 |
| Interest | 1.01 | 0.66 | 0.93 | 1.85 | 2.02 | 4.32 |
| PBDT | 311.60 | 306.36 | 243.58 | 250.71 | 275.05 | 274.22 |
| Depreciation | 43.11 | 41.40 | 44.41 | 41.18 | 40.85 | 40.01 |
| Tax | 64.99 | 63.19 | 43.59 | 43.45 | 52.04 | 52.61 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 3.08 | 3.90 | 5.78 | 9.69 | 9.04 | 8.37 |
| Reported Profit After Tax | 200.42 | 197.87 | 149.80 | 156.39 | 173.12 | 173.23 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 200.42 | 197.87 | 149.80 | 156.39 | 173.12 | 173.23 |
| EPS (Unit Curr.) | 12.82 | 12.70 | 9.63 | 10.06 | 11.15 | 11.16 |
| EPS (Adj) (Unit Curr.) | 12.82 | 12.70 | 9.63 | 10.06 | 11.15 | 11.16 |
| Calculated EPS (Unit Curr.) | 12.80 | 12.68 | 9.62 | 10.06 | 11.15 | 11.16 |
| Calculated EPS (Adj) (Unit Curr.) | 12.80 | 12.68 | 9.62 | 10.06 | 11.15 | 11.16 |
| Calculated EPS (Ann.) (Unit Curr.) | 51.19 | 50.70 | 38.48 | 40.23 | 44.59 | 44.65 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 51.19 | 50.70 | 38.48 | 40.23 | 44.59 | 44.65 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 850.00 | 0.00 | 0.00 |
| Equity | 15.66 | 15.61 | 15.57 | 15.55 | 15.53 | 15.52 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 30.57 | 29.52 | 27.13 | 27.65 | 28.99 | 29.25 |
| PBDTM(%) | 30.47 | 29.46 | 27.02 | 27.44 | 28.78 | 28.80 |
| PATM(%) | 19.60 | 19.03 | 16.62 | 17.12 | 18.11 | 18.19 |
